Anixa Biosciences (ANIX) director exercises 6,000 options, uses 5,428 shares to pay cost
Rhea-AI Filing Summary
Arnold M. Baskies, a director of Anixa Biosciences Inc, exercised employee stock options covering 6,000 shares of common stock on July 27, 2026 at an exercise price of $3.1300 per share. These options were granted on August 23, 2013 and were approaching expiration on August 23, 2026.
To cover the option exercise cost, 5,428 shares of common stock were withheld by Anixa Biosciences Inc at $3.4600 per share. Following this exercise, the related stock option position reported for this grant was reduced to 0 derivative securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 572 shares
Net Buy
3 txns
Insider
Baskies Arnold M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F2 | 6,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,000 | $3.13 | $19K |
| Exercise Price Payment | Common Stock F1 | 5,428 | $3.46 | $19K |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 135,572 shares (Direct)
Footnotes (2)
- F1. The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.
- F2. Right-To-Buy, pursuant to a stock option grant dated August 23, 2013.
Key Figures
Options Exercised: 6000.0000 shares
Option Exercise Price: $3.1300 per share
Shares Withheld: 5428.0000 shares
+3 more
6 metrics
Options Exercised
6000.0000 shares
Employee stock options exercised for common stock on 2026-07-27
Option Exercise Price
$3.1300 per share
Exercise price of employee stock options granted August 23, 2013
Shares Withheld
5428.0000 shares
Common shares withheld to cover exercise price at $3.4600 per share
Withholding Share Price
$3.4600 per share
Price used for shares withheld to pay the option exercise cost
Options Remaining from Grant
0.0000 derivative securities
Total derivative securities following transaction for this option grant
Option Expiration Date
2026-08-23
Expiration date of stock option grant exercised by the director
Key Terms
Employee Stock Option (Right to Buy), exercise price, stock option grant, withheld
4 terms
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy)"
exercise price financial
"Payment of exercise price by delivering or withholding securities"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
stock option grant financial
"pursuant to a stock option grant dated August 23, 2013"
withheld financial
"represents shares withheld by Anixa Biosciences, Inc. to cover the exercise price"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transaction did Arnold M. Baskies report for Anixa Biosciences (ANIX)?
Arnold M. Baskies reported exercising 6,000 employee stock options for Anixa Biosciences common stock. The exercise occurred on July 27, 2026, using options granted in 2013 that were nearing their August 23, 2026 expiration date.
At what price did the ANIX director exercise his stock options?
The ANIX director exercised his options at an exercise price of $3.1300 per share. These options related to 6,000 shares of common stock and were originally granted on August 23, 2013 under a Right-To-Buy stock option grant.
What happened to the option position after the ANIX option exercise?
After the transaction, the director’s reported derivative position from this grant was reduced to 0 stock options. The footnotes explain the options were exercised at this time because they were approaching their August 23, 2026 expiration date.
Were the ANIX transactions part of a Rule 10b5-1 trading plan?
The disclosure indicates the Rule 10b5-1 checkbox was not affirmatively marked for these transactions. No footnote states that the option exercise or share withholding occurred under a pre-arranged Rule 10b5-1 trading plan.